Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Mar
14
2023
 Food Hall Fever: Business & Legal Considerations for Owners, Operators & Vendors ArentFox Schiff LLP
Mar
14
2023
 Insufficiently Specific Pleadings Doom “Naturally Flavored” Lawsuit Keller and Heckman LLP
Mar
14
2023
 Insurance Options for Cannabis Businesses Slowly Improving Bradley Arant Boult Cummings LLP
Mar
13
2023
 FDA Publishes Proposed Rule on Tobacco Product Manufacturing Practices Keller and Heckman LLP
Mar
13
2023
 Alabama Medical Cannabis Commission Set for Key April Votes Bradley Arant Boult Cummings LLP
Mar
13
2023
 Status of FDA’s COVID-19 Guidance Documents When Public Health Emergency Expires Keller and Heckman LLP
Mar
12
2023
 Washington State Based Business Offered USDA Funding to Help Increase American-Made Fertilizer Production U.S. Department of Agriculture
Mar
10
2023
 Ramifications of FDA’s Proposed Action Levels for Heavy Metals in Baby Food Womble Bond Dickinson (US) LLP
Mar
10
2023
 HHS Argues Pharmaceutical Proposal Involves Quid Pro Quo Exchanges ArentFox Schiff LLP
Mar
10
2023
 Update: Letter to Powdered Infant Formula Industry Keller and Heckman LLP
Mar
9
2023
 Leader of International Drug Trafficking Organization Pleads Guilty to Cocaine Trafficking Conspiracy The U.S. Department of Justice
Mar
9
2023
 Real or Not Real? The Difference Between Legal Delta-8/Delta-10 THC and Illegal Delta-8/Delta-10 THCO Bradley Arant Boult Cummings LLP
Mar
9
2023
 Patent Law Principles Apply to Claim Scope: Orange Book Delisting and Listing and Regulations McDermott Will & Emery
Mar
8
2023
 This Week in 340B: February 28 – March 6, 2023 McDermott Will & Emery
Mar
8
2023
 The FDA’s Proposed Rule on Food Labeling: Nutrient Content Claims and Definition of ‘‘Healthy’’ Stubbs Alderton & Markiles, LLP
Mar
8
2023
 The Cannabis Paradox: Clarifying the Confusing Legality of Delta-8, THC-O, THCV, and Synthetically Derived THC Stark & Stark
Mar
7
2023
 HHS-OIG Foregoes Sanctions On Drug Manufacturer For Providing Free Drugs To Patients Waiting For Insurance Authorization Barnes & Thornburg LLP
Mar
7
2023
 DEA Proposes Rule for Post-PHE Telemedicine Sheppard, Mullin, Richter & Hampton LLP
Mar
7
2023
 FDA Launches Dietary Supplement Ingredient Directory Keller and Heckman LLP
Mar
7
2023
 Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023 Epstein Becker & Green, P.C.
Mar
7
2023
 The Wait is Over . . . Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways Epstein Becker & Green, P.C.
Mar
7
2023
 EPA Announces Both EPA and FDA to Conduct Virtual Public Meeting and Request Comments on Modernizing Their Approach to Oversight of Certain Products Bergeson & Campbell, P.C.
Mar
6
2023
 Old North State Report – March 6, 2023 Nelson Mullins
Mar
6
2023
 Federal Circuit Affirms Delisting of REMS System Patent from FDA Orange Book Mintz
Mar
6
2023
 Update on FDA’s Prevention Strategies to Enhance Food Safety Keller and Heckman LLP
Mar
4
2023
 NIOSH Announces Publication of Article on the Results of 2019 Survey of Engineered Nanomaterial Occupational Health and Safety Practices Bergeson & Campbell, P.C.
Mar
3
2023
 Justice Department Announces Application Form for Marijuana Pardon Certificates The U.S. Department of Justice
Mar
3
2023
 FDA Issues Draft Guidance on Labeling of Plant-Based Milk Alternatives Epstein Becker & Green, P.C.
Displaying 2409 - 2436 of 12182
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters